Franklin Covey

Franklin Covey reported Q2 FY2026 revenue of $59.65 million, beating analyst estimates, but recorded a loss of $0.17 per share due to restructuring charges and higher stock-based compensation. Adjusted EBITDA improved to $4.1 million, deferred revenue and free cash flow rose significantly, and the balance sheet shows more cash than liabilities. Management reaffirmed its full-year guidance of $265–275 million in revenue and $28–33 million in adjusted EBITDA, but still sees near-term profitability pressure and is investing in AI solutions and expansion into the healthcare market. » Plus sur de.investing.com

At the annual meeting, shareholders elected seven directors — including Anne H. Chow and Craig Cuffie — and voted in an advisory vote to approve the board compensation as disclosed in the proxy statement. Deloitte & Touche was ratified as the independent auditor for the fiscal year ending August 31, 2026. Franklin Covey also released Q1 results that missed expectations: EPS of -$0.27 versus $0.04 expected, and revenue of $64 million versus $66.68 million forecast. » Plus sur de.investing.com

Franklin Covey reported first-quarter 2026 revenue of $64.0 million (‑7% year-on-year) and adjusted EBITDA of $3.7 million (‑52%). Earnings per share dropped to ‑$0.27, well below expectations, and free cash flow was ‑$3.7 million. Management confirmed the full-year guidance of constant‑currency $265–275 million in revenue and adjusted EBITDA of $28–33 million, citing seasonality and ongoing restructuring costs ($3.4 million). Strategic priorities are AI integration and the growing deferred subscription volume ($100.2 million). » Plus sur de.investing.com